Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
Behr
T M
TM
Department of Cardiology, Klinikum Innenstadt, Munich, Germany.
Richter
K
K
Fischer
P
P
Spes
C H
CH
Meiser
B
B
Reichart
B
B
Pongratz
D
D
Feucht
H
H
Theisen
K
K
Angermann
C E
CE
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000917:Antibody Formation; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003181:Complement C4 / Q000032:analysis; D015935:Complement C4b; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D010446:Peptide Fragments / Q000032:analysis; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D003181:Complement C4; D007166:Immunosuppressive Agents; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus